ABSTRACT
The current study aimed to develop novel pH independent microparticles loaded with ropinirole (ROP) for sustained drug release. Eudragit RS 100 was used as release retardant and microparticles were fabricated by oil-in-oil emulsion solvent evaporation method. A three-factor three-level Box-Behnken design using Design-Expert software was employed to optimize formulation variables. Ropinirole loaded microparticles were evaluated with respect to morphology, particle size, encapsulation efficiency, and in vitro release profile. Optical microscopy and SEM micrographs indicated spherical shape with smooth surface and well-defined boundary. The particle size was in the range of 98.86 to 236.29 μm, being significantly increased with increasing polymer concentration. Higher polymer load also increased the thickness of internal polymer network, which led to reduced drug loss and higher entrapment efficiency (89%). The cumulative in vitro release was found to be in the range of 54.96 to 99.36% during the release studies (12 h) following zero order release kinetics and non-Fickian diffusion pattern. The developed microparticles have the potential to sustain the release of ropinirole, which may lead to a reduction in its adverse effects and improved management of Parkinson’s disease.
Similar content being viewed by others
REFERENCES
Ahlskog JE. Pathological behaviors provoked by dopamine agonist therapy of Parkinson’s disease. Physiol Behav. 2011;104(1):168–72.
Nanaki SG, Koutsidis IA, Koutri I, Karavas E, Bikiaris D. Miscibility study of chitosan/2-hydroxyethyl starch blends and evaluation of their effectiveness as drug sustained release hydrogels. Carbohydr Polym. 2012;87(2):1286–94.
Sweetman SC. Martindale the complete drug reference. 36th ed. London: Pharmaceutical press; 2009. 816 p.
Hubble J, Koller WC, Atchison P, Taylor AC, Citerone DR, Zussman BD, et al. Linear pharmacokinetic behavior of ropinirole during multiple dosing in patients with Parkinson’s disease. J Clin Pharmacol. 2000;40(6):641–6.
Kaye CM, Nicholls B. Clinical pharmacokinetics of ropinirole. Clin Pharmacokinet. 2000;39(4):243–54.
Garbayo E, Ansorena E, Blanco-Prieto MJ. Drug development in Parkinson’s disease: from emerging molecules to innovative drug delivery systems. Maturitas. 2013;76(3):272–8.
D’Aurizio E, Van Nostrum C, Van Steenbergen M, Sozio P, Siepmann F, Siepmann J, et al. Preparation and characterization of poly (lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug. Int J Pharm. 2011;409(1):289–96.
Hurley MJ, Jenner P. What has been learnt from study of dopamine receptors in Parkinson’s disease? Pharmacol Ther. 2006;111(3):715–28.
Salawu F, Olokoba A, Danburam A. Current management of Parkinson’s disease. Ann Afr Med. 2010;9(2).
Pandya M, Kubu CS, Giroux ML. Parkinson disease: not just a movement disorder. Cleve Clin J Med. 2008;75(12):856–64.
Gaignaux A, Réeff J, Siepmann F, Siepmann J, De Vriese C, Goole J, et al. Development and evaluation of sustained-release clonidine-loaded PLGA microparticles. Int J Pharm. 2012;437(1):20–8.
Agnihotri N, Mishra R, Goda C, Arora M. Microencapsulation—a novel approach in drug delivery: a review. Indo Global J Pharm. 2012;2(1):1–20.
Dubey R. Microencapsulation technology and applications. Def Sci J. 2009;59(1):82–95.
El-Bagory IM, Hosny EA, Al-Suwayeh SA, Mahrous GM, Al-Jenoobi FI. Effects of sphere size, polymer to drug ratio and plasticizer concentration on the release of theophylline from ethylcellulose microspheres. Saudi Pharm J. 2007;15(3–4):213–7.
Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int J Pharm. 2008;363(1):26–39.
Park J, Ye M, Park K. Biodegradable polymers for microencapsulation of drugs. Molecules. 2005;10(1):146–61.
Kılıçarslan M, Baykara T. The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres. Int J Pharm. 2003;252(1):99–109.
Horoz BB, Kiliçarslan M, Yüksel N, Baykara T. Influence of aluminum tristearate and sucrose stearate as the dispersing agents on physical properties and release characteristics of Eudragit RS microspheres. AAPS PharmSciTech. 2006;7(1):E111–7.
Govender S, Pillay V, Chetty D, Essack S, Dangor C, Govender T. Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres. Int J Pharm. 2005;306(1):24–40.
Mujtaba A, Ali M, Kohli K. Statistical optimization and characterization of pH-independent extended-release drug delivery of cefpodoxime proxetil using Box–Behnken design. Chem Eng Res Des. 2014;92(1):156–65.
Yang C-R, Zhao X-L, Hu H-Y, Li K-X, Sun X, Li L, et al. Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers. Chem Pharm Bull. 2010;58(5):656–61.
Gannu R, Palem CR, Yamsani VV, Yamsani SK, Yamsani MR. Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: formulation optimization, ex vivo and in vivo characterization. Int J Pharm. 2010;388(1–2):231–41.
Trapani A, Laquintana V, Denora N, Lopedota A, Cutrignelli A, Franco M, et al. Eudragit RS 100 microparticles containing 2-hydroxypropyl-β-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies. Eur J Pharm Sci. 2007;30(1):64–74.
Souza MC, Marchetti JM. Development of albendazole sulfoxide-loaded Eudragit microparticles: a potential strategy to improve the drug bioavailability. Adv Powder Technol. 2012;23(6):801–7.
Raffin R, Colomé L, Pohlmann A, Guterres S. Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles. Eur J Pharm Biopharm. 2006;63(2):198–204.
Yamada T, Onishi H, Machida Y. Sustained release ketoprofen microparticles with ethylcellulose and carboxymethylethylcellulose. J Control Release. 2001;75(3):271–82.
Hou C-D, Wang J-X, Le Y, Zou H-K, Zhao H. Preparation of azithromycin nanosuspensions by reactive precipitation method. Drug Dev Ind Pharm. 2012;38(7):848–54.
Li J-L, Zhu Y-W, Ye B, Zhao Z-C, Chang Z-Q, Serra CA. Fabrication and characteristics of Li4SiO4 pebbles by a novel capillary-based microfluidic wet process. J Nucl Mater. 2013;440(1–3):283–7.
Shi K, Bi H, Jiang Y. Characterization of physiochemical and biological properties of spherical protein crystals for sustained release. Asian J Pharm Sci. 2013;8(1):58–63.
Josephine J, Mehul R, Wilson B, Shanaz B, Bincy R. Formulation and in vitro evaluation of floating microspheres of anti-retro viral drug as a gastro retentive dosage form. Int J Pharm Chem Res. 2011;1:519–27.
Gupta S, Kaur J, Verma R. Study on formulation and evaluation of ropinirole hydrochloride loaded microspheres using polymers blend of ethyl cellulose and carbopol 934P. Int J Curr Res Chem Pharm Sci. 2014;1(5):48–55.
Haznedar S, Dortunç B. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int J Pharm. 2004;269(1):131–40.
Deshmukh RK, Naik JB. Aceclofenac microspheres: quality by design approach. Mater Sci Eng C. 2014;36:320–8.
Varshosaz J, Tabbakhian M, Zahrooni M. Development and characterization of floating microballoons for oral delivery of cinnarizine by a factorial design. J Microencapsul. 2007;24(3):253–62.
Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–33.
Sharma VK, Mazumder B. Gastrointestinal transition and anti-diabetic effect of Isabgol husk microparticles containing gliclazide. Int J Biol Macromol. 2014;66:15–25.
Dehghan S, Aboofazeli R, Avadi M, Khaksar R. Formulation optimization of nifedipine containing microspheres using factorial design. Afr J Pharm Pharmacol. 2010;4(6):346–54.
Panchal MS, Patel H, Bagada A, Vadalia K. Formulation and evaluation of mouth dissolving film of ropinirole hydrochloride by using pullulan polymers. Int J Pharm Res Allied Sci. 2012;1(3):60–72.
Basu S, Adhiyaman R. Preparation and characterization of nitrendipine-loaded Eudragit RL 100 microspheres prepared by an emulsion-solvent evaporation method. Trop J Pharm Res. 2008;7(3):1033–41.
Devrim B, Canefe K. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi emulsion solvent diffusion method: effect of variables. Acta Pol Pharm Drug Res. 2006;63(6):521–4.
Willmann S, Edginton AN, Dressman JB. Development and validation of a physiology-based model for the prediction of oral absorption in monkeys. Pharm Res. 2007;24(7):1275–82.
Hijo T, Campos AA, Costa JMG, Silva EK, Azevedo VM, Yoshida MI, et al. Physical and thermal properties of oregano (Origanum vulgare L.) essential oil microparticles. J Food Process Eng. 2015;38(1):1–10.
Mukhopadhyay HK, Das SK, Bhowmik M, Ray S, Rajabalaya R, Ghosh L, et al. Preparation and characterization of polymethacrylate-based matrix microspheres of carbamazepine using solvent evaporation method. Farmacia. 2014;62(1):137–58.
Karavelidis V, Karavas E, Giliopoulos D, Papadimitriou S, Bikiaris D. Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior. Int J Nanomedicine. 2011;6:3021–32.
Park J-M, Park S-J. Preparation and characterization of water-soluble microcapsule for sustained drug release using Eudragit RS 100. Macromol Res. 2010;18(12):1191–4.
Chaisri W, Hennink WE, Okonogi S. Preparation and characterization of cephalexin loaded PLGA microspheres. Curr Drug Deliv. 2009;6(1):69–75.
Perumal D. Microencapsulation of ibuprofen and Eudragit® RS 100 by the emulsion solvent diffusion technique. Int J Pharm. 2001;218(1):1–11.
Hong Y, Gao C, Shi Y, Shen J. Preparation of porous polylactide microspheres by emulsion‐solvent evaporation based on solution induced phase separation. Polym Adv Technol. 2005;16(8):622–7.
Mao S, Shi Y, Li L, Xu J, Schaper A, Kissel T. Effects of process and formulation parameters on characteristics and internal morphology of poly (d, l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Eur J Pharm Biopharm. 2008;68(2):214–23.
Abdallah MH, Sammour OA, El-ghamry HA, El-Nahas HM, Barakat W. Development and characterization of controlled release ketoprofen microspheres. J Appl Pharm Sci. 2012;2(3):60–7.
NHire N, Derle D. Development and evaluation of drug loaded Eudragit RS-100 microspheres for colon specific drug delivery system. Pharm Innov J. 2014;2(12):67–78.
Regnier-Delplace C, Thillaye du Boullay O, Siepmann F, Martin-Vaca B, Degrave N, Demonchaux P, et al. PLGA microparticles with zero-order release of the labile anti-Parkinson drug apomorphine. Int J Pharm. 2013;443(1–2):68–79.
Lamprecht A, Yamamoto H, Takeuchi H, Kawashima Y. Microsphere design for the colonic delivery of 5-fluorouracil. J Control Release. 2003;90(3):313–22.
Behera B, Sahoo S, Dhal S, Barik B, Gupta B. Characterization of glipizide-loaded polymethacrylate microspheres prepared by an emulsion solvent evaporation method. Trop J Pharm Res. 2008;7(1):879–85.
Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5(1):37–42.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kashif, P.M., Madni, A., Ashfaq, M. et al. Development of Eudragit RS 100 Microparticles Loaded with Ropinirole: Optimization and In Vitro Evaluation Studies. AAPS PharmSciTech 18, 1810–1822 (2017). https://doi.org/10.1208/s12249-016-0653-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-016-0653-5